EPO Patent EP4630402A1: Sulfonyl Derivatives as CCR6 Inhibitors
Summary
The European Patent Office has published patent application EP4630402A1 concerning sulfonyl derivatives as CCR6 inhibitors, with F. Hoffmann-La Roche AG listed as the applicant. This publication details chemical compounds and their potential therapeutic applications.
What changed
This document is a publication of a European patent application (EP4630402A1) by F. Hoffmann-La Roche AG, detailing novel sulfonyl derivatives identified as CCR6 inhibitors. The publication includes extensive International Patent Classification (IPC) codes related to organic chemistry and pharmaceutical applications, specifically A61K (Preparations for medical, dental or toilet purposes) and A61P (Specific therapeutic activity of chemical compounds). The designated states indicate broad European coverage for this patent.
As a patent publication, this document does not impose direct regulatory obligations or compliance deadlines on entities. However, it is significant for pharmaceutical companies and drug manufacturers involved in research and development, particularly in areas related to immunology or inflammatory diseases where CCR6 plays a role. Companies should note this patent filing as part of their competitive intelligence and intellectual property landscape monitoring.
Source document (simplified)
SULFONYL DERIVATIVES AS CCR6 INHIBITORS
Publication EP4630402A1 Kind: A1 Mar 18, 2026
Applicants
F. Hoffmann-La Roche AG
Inventors
BAUTISTA SARMIENTO, Lady Johanna, CALS, Joseph Maria Gerardus Barbara, DE BROUWER, Johanna Hendrika Angelique, DE KIMPE, Vera, DERETEY, Eugen, LAZO MORI, Alger Ayrton, MANDERS, Daan Marten Jorrit, NABUURS, Sander Bernardus
IPC Classifications
C07D 209/42 20060101AFI20240614BHEP C07D 209/46 20060101ALI20240614BHEP C07D 211/96 20060101ALI20240614BHEP C07D 213/64 20060101ALI20240614BHEP C07D 213/81 20060101ALI20240614BHEP C07D 213/82 20060101ALI20240614BHEP C07D 217/24 20060101ALI20240614BHEP C07D 237/14 20060101ALI20240614BHEP C07D 401/12 20060101ALI20240614BHEP C07D 471/04 20060101ALI20240614BHEP C07D 487/04 20060101ALI20240614BHEP C07C 323/22 20060101ALI20240614BHEP A61K 31/4468 20060101ALI20240614BHEP A61P 37/02 20060101ALI20240614BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.